Healio will have live coverage of this year’s ESCMID Global, one of the largest medical conferences dedicated to infectious diseases and clinical microbiology in the world. Clinical Infectious ...

Lynae Darbes, PhD, discusses what her research results mean when it comes to implementation of self-testing and counselling ...

Despite being effective, PrEP uptake in Europe remains low due to issues like cost, access, and stigma, hindering its ...

There’s no cure yet for HIV or stage 3 HIV, also known as AIDS. However, remarkable advancements in treatments and clinical understanding of how HIV progresses are allowing people with HIV to ...

The clinical consequences of chronic HBV/HIV coinfection have received less ... Immune reconstitution disease might further muddy the picture of coinfected individuals. Carr and colleagues ...

no treatment can yet completely eradicate HIV once it has taken hold. But promising results from a recent clinical trial suggest that broadly neutralizing antibody therapy (bNAbs) may be able to ...

The drug, which works by blocking HIV from entering and multiplying in human cells, remained in the body for at least 56 weeks, according to the phase 1 randomised controlled trial.

A six-monthly injection to reduce the risk of HIV transmission is being offered to sexually active women in parts of England as part of a new clinical study. The study will be carried out in ...

Using recent advances in biological and medical sciences, a new candidate human immunodeficiency virus (HIV) vaccine has been developed and tailor-designed for a phase III clinical trial in Kenya.